Loading transcript...
Click for full transcript
Chapters & Sections (270)
▼
00:01
Host Introduction and Guest Overview
00:32
Personal Inspiration from the Sydney Olympics
01:02
Statistics on Performance Enhancers in Olympic Athletes
01:33
Economic Inequity for Olympians
02:03
Debate on Nationalism vs. Human Unity in Sports
02:36
Political Overtones in International Competitions
03:09
Impact of Political Context on Olympic Events
03:39
Case Study: Icarus Documentary and Athlete Exposure
04:10
Legal Status of Steroids and Other Enhancers
05:14
Distinguishing Legal vs. Banned Substances in Competition
05:45
Unintended Consequences of Mislabelled Supplements
06:16
Prevalence of Contaminated Supplements in the Market
06:47
Allegations of State‑Sponsored Doping Cases
07:18
Critique of Anti‑Doping Authority Practices
07:48
Doping Statistics in Track and Cycling
08:19
IV Restrictions in UFC and Other Sports
09:21
Health Testing as an Alternative to Drug Testing
09:52
Testosterone Exemptions and Endocrine Concerns
10:22
Pride Organization and Steroid Culture
11:25
Philosophical Debate on Fairness and Consent
11:56
Athlete Perception of Cheating in the Olympics
12:26
Open vs. Zero-Testing Frameworks
12:58
Olympic Amateurism and Professionalism Shift
13:30
Public Desire for Enhanced Performance in Sports
14:00
UFC as a Model for Unrestricted Competition
14:31
Criteria for Selecting Athletes in Enhanced Games
15:02
Impact of Hormone Use on Olympic Eligibility
15:32
Olympic Eligibility and Cooling-Off Policies
16:03
Prize Incentives for World Record Breakers
16:35
Risk Assessment for Enhanced Athletes
17:05
Genetic Lottery and Natural Competition Narrative
17:37
Apollo Analogy for Human Potential
18:07
Historical Doping Cases and Public Perception
18:38
Documentary Casting Call and Athlete Interest
19:09
National Pride and International Pressure
19:40
Investor Perspective on Technological Advancement
20:12
Athlete Drug Testing and Regulatory Gaps
20:42
Historical UFC Doping Practices
21:15
IOC Governance and Accountability Issues
22:19
Sport Portfolio for Enhanced Games
22:50
Challenges of Integrating MMA into Enhanced Games
23:21
Banned Peptides and State Commission Testing
23:52
Objective vs Performance in Combat Sports
24:22
Age-Related Decline and Enhancement Appeal
24:54
VOR Belfort Testosterone Exemption Controversy
25:27
Long-Term Effects of TRT on Fighter Physiology
27:01
Need for Clinical Supervision in Enhancement Practices
28:35
Sport Inclusion Criteria Based on Media Impact and Cost
29:07
Boxing Enhancement Debate and Athlete Safety
31:10
Gym Recovery Experience
31:41
Age-Related Performance and Personal Goals
32:11
Psychedelics and Medical Enhancement Discussion
32:42
State-Sponsored Doping Programs
33:13
Anti-Aging Research and Public Perception
34:17
Vanity vs. Functional Enhancement Debate
34:47
Anabolic Steroids for Elderly Muscle Loss
35:20
Medical Community’s Stance on Performance Drugs
35:51
Body Autonomy and Societal Change
36:23
Historical Definition of Medicine
36:56
Legal Constraints on Performance Enhancement
37:27
Cognitive Enhancers and Academic Use
37:58
Neuroscience Research on Long-Term Use
38:30
Personal Approach to Safe Enhancement
39:31
Professor David’s Risk Scoring Framework
40:35
Ranking of Alcohol and Heroin as Highest Risks
42:09
Personal Decision to Avoid Alcohol
42:40
First Psychedelic Experience and Its Impact
43:11
Advocacy for Medical Availability of Psychedelics
44:12
Psychedelic Therapy for Veterans and PTSD
45:44
FDA Advisory Committee Decision on MDMA
46:48
Conservative Approach to Clinical Data
47:19
Funding Constraints of Nonprofit Research
47:49
Scale of Clinical Trials and Public Perception
48:00
Hope for FDA Approval of MDMA
48:34
Marijuana Legalization Across States
49:25
State-Level Decriminalization of Psilocybin
49:55
Psychedelics versus Cannabis in Public Discourse
51:31
Microdosing and Therapeutic Contexts
51:40
Historical Use of Psychedelics in Cults
52:03
Pharmacological Differences Between THC and Edibles
53:06
High-Dose Edible Experiences and Risks
54:08
Modern Perspectives on Psychedelic Therapy
54:39
Discussion of Physical Risks with Psychedelics
55:10
Collecting Online Reports of Negative Effects
56:13
Recommendations Against Mixing Alcohol, Psychedelics, and Cannabis
57:47
Microdosing as a Non-Commercial Practice
58:18
Heart Impact of Psychedelics and Microdosing Frequency
58:50
Adulteration Issues in the Market
59:55
Cognitive Testing Results on Microdosing
1:00:26
Neurobiological Rationale for LSD and Mood
1:01:28
Advocating Scientific Evidence over Anecdote
1:01:59
Body Autonomy and Informed Consent
1:02:32
Moral Debate on Creatine Use
1:03:02
Scientific Evidence for Performance Enhancement
1:03:33
Capital Raising and Venture Funding
1:04:04
Infrastructure Waste in Traditional Olympics
1:04:35
Three‑Year Financial Sustainability Plan
1:05:07
Unexpected Brand Interest and Sponsorship Strategy
1:05:38
Nike’s Core Mythology and Market Positioning
1:06:10
Location Strategy for Enhanced Games
1:06:41
Decentralized Infrastructure and Television Innovation
1:07:12
Athlete Compensation Model
1:08:13
Broadcast Rights and Global Partnerships
1:09:13
Streaming Strategy and Platform Considerations
1:09:45
Network Deal Structure and Revenue Projections
1:10:48
College Sports vs. Olympic Financial Models
1:11:19
Broadcast Partnerships and New Sponsorship Avenues
1:11:50
Potential Pharma Market Shift with Enhanced Athletes
1:12:21
Comparing Enhancement Drug Value to AI Market
1:12:52
Farmers and the Changing Landscape of GP1s
1:13:24
Side Effects and Personal Monitoring Practices
1:14:26
Self-Testing and Off-Label Use Statistics
1:14:58
Industry Shift Toward Preventive Health
1:15:29
Aging as a Non-Disease Concept
1:16:00
Medicine’s Role in Enhancing Quality of Life
1:16:32
Public Perception and Future Use of Enhancement Drugs
1:17:02
Economic Incentives for Olympic Athletes
1:17:33
Projected Performance Gains from Enhancements
1:18:04
Improving Athlete Living Conditions for Better Focus
1:18:34
Athlete Village Party Atmosphere
1:19:05
Single Bed Policy and Public Reaction
1:19:38
Impact of Sexual Activity on Testosterone Levels
1:20:10
Core Sports with Low Infrastructure Costs
1:20:42
Cycling and Other Niche Olympic Disciplines
1:21:12
Curling Participation Statistics
1:21:44
Beta Blockers in Classical Music Performance
1:22:15
Beta Blockers and Video Game Players
1:22:46
Illegal Distribution of Beta Blockers
1:23:16
Drug Dealer Background and Legal Issues
1:23:47
Impact of Drug Distribution on Organized Crime
1:24:18
Legalization Debate and Public Health Concerns
1:24:49
Supply Chain Cleanliness and Taxation Proposals
1:25:22
Corporate Sponsorships of the Olympics
1:25:54
Addictive Substances and Public Health Messaging
1:26:26
Challenges of Shifting Public Opinion
1:26:58
Long‑Term Conversations as a Tool for Change
1:27:30
Impact of Podcasts and Social Media Clips
1:28:02
Historical Examples of Industry Manipulation
1:28:35
Opening the Overton Window on Performance‑Enhancing Drugs
1:29:07
Comparing Risk Levels of Steroids and Psychedelics
1:29:39
Survey Data on Synthetic Opioids and Other Substances
1:30:10
Discussion of Buprenorphine vs. Methadone Treatment
1:30:40
Cannabis Risk Assessment and Color‑Coding System
1:31:11
Physical vs. Social Harm in Drug Ratings
1:31:41
Crime and Substance Use Correlation Debate
1:32:12
Comparative Harm of Cocaine, Tobacco, and Cannabis
1:32:43
Advocacy for Personal Autonomy in Substance Use
1:33:15
Risk Assessment of Space Exploration vs. Drug Use
1:33:47
Societal Attitudes Toward Positive Risk‑Taking
1:34:21
Public Perception of Food Safety
1:34:52
Comparing American and British Food Standards
1:35:25
Marketing of Sugary Cereals to Children
1:35:55
Need for Accurate Food Disclosure
1:36:27
Seed Oils and Industry Resistance
1:36:59
Business Model for Performance Enhancement
1:37:31
Capitalism as a Driver of Positive Change
1:38:01
Challenges of Accurate Information in the Digital Age
1:38:33
Trust Dynamics Between Podcasts and Traditional Media
1:39:03
Transgender Athlete Participation in Enhanced Games
1:39:34
Defining Fairness and Balance for Transgender Competitors
1:40:07
Ethical Considerations of Hormone Regulation in Sports
1:40:39
Biological Advantages and Transgender Inclusion Debate
1:41:10
Proposed Gender Categories for Enhanced Sports
1:42:13
Chromosomal Classification vs. Gender Labels
1:42:43
Transgender Representation in Large-Scale Competitions
1:43:14
Enhancement Strategies for Transgender Athletes
1:43:45
Biological Male Transition and Performance Metrics
1:44:17
Case Study: Leah Thomas and World Record Contention
1:44:47
Physiological Disparities Between Biological Females and Transgender Athletes
1:45:19
Argumentation on Testosterone Blockers and Muscle Mass
1:45:50
Genetic Editing and the Future of Olympic Eligibility
1:46:21
CRISPR-Edited Children and Competitive Fairness
1:46:51
Transhumanism, BCI Implants, and Olympic Adaptation
1:47:24
Vision for Future Performance Enhancement Showcases
1:47:55
Ancient Olympic Practices and Modern Comparisons
1:48:27
Historical Use of Pain Relief, Hormones, and Psychedelics in Ancient Games
1:48:58
Gender Identity and Competition Rules in Antiquity
1:49:28
Cultural Shifts and the Role of Women in Early Olympic History
1:50:01
Physiological Changes from Exogenous Testosterone
1:51:05
Historical Use of Testosterone in Competitive Sports
1:52:06
Transitioning to Male Physique for Competitive Advantage
1:53:10
Individual Choice vs. Societal Standards in Bodybuilding
1:54:12
Medical Oversight and Public Doctor Requirement
1:55:15
Health Monitoring and Disqualification Thresholds
1:56:47
CrossFit Drug Testing Procedures and Banned Substances
1:57:50
Asthma Statistics and Swimmer Claims
1:58:23
Case Study of a Cyclist with Therapeutic Exemption
1:58:55
Testing Requirements for Asthma in Competition
1:59:27
Potential for Abuse and Home Country Testing
1:59:58
Chlorine Exposure as a Factor in Swimmer Asthma
2:00:29
Discussion of Therapeutic Use Exemptions and Abuse
2:01:32
Criticism of Olympic Funding and Athlete Exploitation
2:02:04
Promotion of New Initiative and Social Media Outreach
2h 58m⏭ 2
2h 21m⏭ 3
2h 53m⏭ 2
3h 1m⏭ 2
2h 54m⏭ 2
3h 35m
3h 7m⏭ 2
2h 39m⏭ 2
2h 58m⏭ 2
2h 34m⏭ 3
2h 19m
2h 49m⏭ 2
48m⏭ 1
1h 22m
1h 16m⏭ 4
31m⏭ 1
1h 50m⏭ 3
1h 0m⏭ 1
4h 6m⏭ 2
2h 15m⏭ 2
1h 1m
1h 28m⏭ 2
1h 42m⏭ 3
1h 0m⏭ 2